University of California San Francisco
Helen Diller Family Comprehensive Cancer Center

Women with Dense Breasts May Not Need More Screening

Women with Dense Breasts May Not Need More Screening

May 18, 2015

As the debate continues to swirl around the medical significance of dense breasts and whether extra screening should be done, a new study led by UC San Francisco has found that women with dense breasts may need only routine mammograms unless they are at high risk.

UCSF to Study Benefits of Personal Approach to Breast Cancer Screening

UCSF to Study Benefits of Personal Approach to Breast Cancer Screening

March 25, 2015

A research team at UC San Francisco has won a five-year award of $14.1 million from the Patient-Centered Outcomes Research Institute (PCORI) to investigate whether a personalized approach to breast cancer screening is as safe and effective as annual mammograms.
 
Genetic Variant Protects Some Latina Women from Breast Cancer

Genetic Variant Protects Some Latina Women from Breast Cancer

October 20, 2014

An international research collaboration led by UC San Francisco researchers has identified a genetic variant common in Latina women that protects against breast cancer.

image

Bone Drugs May Not Protect Osteoporotic Women from Breast Cancer

August 11, 2014

Osteoporosis drugs known as bisphosphonates may not protect women from breast cancer as had been thought, according to a new study led by researchers at UC San Francisco.
 

Cancer Categories Recast in Largest-Ever Genomic Study

Cancer Categories Recast in Largest-Ever Genomic Study

August 7, 2014

New research partly led by UC San Francisco-affiliated scientists suggests that one in 10 cancer patients would be more accurately diagnosed if their tumors were defined by cellular and molecular criteria rather than by the tissues in which they originated, and that this information, in turn, could lead to more appropriate treatments.

New Breast Cancer Results Illustrate Promise and Potential of I-SPY 2 Trial

New Breast Cancer Results Illustrate Promise and Potential of I-SPY 2 Trial

April 7, 2014

In an innovative clinical trial led by UC San Francisco, the experimental drug neratinib along with standard chemotherapy was found to be a beneficial treatment for some women with newly diagnosed, high-risk breast cancer.